multi picture research hospital aerovectrx happy better
AerovectRx Corporation is an aerosol therapeutic company providing
proprietary dosage-controlled solutions to the $20 billion inhaled drug
delivery market. Our FDA-cleared AeroCell™ disposable drug cartridge is
unique to the industry and is designed to improve patient compliance and
eliminate cross contamination. Our device and disposable product platform
is uniquely suited to deliver a wide variety of vaccine and therapies varying
from multiple-use mass immunizations, specialty pharmaceutical and
personal home care use. The technology was developed by the U.S. CDC
and licensed exclusively to AerovectRx.
Learn more...
grey gray line
Recent Headlines:
 
AerovectRx Names Tom Callaway as CEO
View PDF

AerovectRx Receives $250,000 Georgia Research Alliance VentureLab Phase III Award
View PDF



 
Recent/Upcoming Events:
 
Sept. 24, 2008 / Atlanta, GA
Georgia Life Sciences Summit 2008
CEO David Johnston, Ph.D. - Panelist Speaker
http://www.informedhorizons.com/summit2008/

October 23 - 25, 2008 / Orlando, FL
22nd Annual North American Cystic Fibrosis Conference
http://www.nacfconference.org/

December 4-5, 2008 / Palm Beach, FL
Southeastern BIO Investor Forum 2008
http://www.sebio.org/investorforum/2008/
AerovectRx © 2006 - 2008 | Privacy | Legal
This site is best viewed in Firefox or Internet Explorer 7.